Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer - Stephenson, C M; Levin, R D; Spector, T; Lis, C G (Cancer Chemother Pharmacol, 2013)